SHA:688193 Revenue

In the year 2025, Shanghai Rendu Biotechnology had annual revenue of 162.06M CNY, down -8.62%. Shanghai Rendu Biotechnology had revenue of 42.91M in the quarter ending December 31, 2025, a decrease of -8.13%.

Revenue

162.06M

Revenue Growth

-8.62%

P/S Ratio

12.27

Revenue / Employee

483.77K

Employees

290

Market Cap

1.99B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	162.06M	-15.29M	-8.62%
Dec 31, 2024	177.35M	12.94M	7.87%
Dec 31, 2023	164.41M	-139.44M	-45.89%
Dec 31, 2022	303.85M	11.54M	3.95%
Dec 31, 2021	292.31M	42.40M	16.97%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chemclin Diagnostics	353.32M
Medicalsystem Biotechnology	1.47B
Guangdong Hybribio Biotech	691.16M
Berry Genomics Co.,Ltd	941.16M
Shanghai Labway Clinical Laboratory	1.52B
Thalys Medical Technology Group	1.25B
SMO ClinPlus CO.,LTD.	819.09M
Cowealth Medical China	777.03M

Revenue Rankings